amikacin has been researched along with Retinal Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dollin, M; Garg, SJ; Hsu, J; Pitcher, J; Reddy, S; Storey, P; Vander, J; Vojtko, J | 1 |
| Karthik, H; Lake, SR; Richards, AD; Stewart, C | 1 |
| Dollin, M; Fang-Yen, NH; Garg, SJ; Hsu, J; Pitcher, JD; Storey, P; Vander, J | 1 |
| Peng, KL; Tsai, TH | 1 |
| Helbig, H; Widmer, S | 1 |
| Grizzard, WS | 1 |
| Dawidex, GM; Habib, NE; Headon, MP; Malik, TY; Price, NJ | 1 |
| Campochiaro, PA; Lim, JI | 1 |
| Chobaz, C; Grounauer, PA; Piguet, B | 1 |
| Trese, MT; Winkler, BS | 1 |
10 other study(ies) available for amikacin and Retinal Diseases
| Article | Year |
|---|---|
The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Topics: Administration, Topical; Aged; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Case-Control Studies; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Male; Middle Aged; Ophthalmic Solutions; Retinal Diseases; Retrospective Studies; Vancomycin; Visual Acuity; Vitreous Body | 2014 |
Bilateral subretinal abscesses: the first case of disseminated Nocardia beijingensis in Australia.
Topics: Abscess; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Native Hawaiian or Other Pacific Islander; Nocardia; Nocardia Infections; Retinal Diseases; Trimethoprim, Sulfamethoxazole Drug Combination; Vitrectomy | 2015 |
MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Bacteria; Ceftazidime; Drug Combinations; Drug Substitution; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body | 2016 |
Metastatic endophthalmitis combined with subretinal abscess in a patient with diabetes mellitus--a case report.
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endophthalmitis; Epidural Abscess; Eye Infections, Bacterial; Humans; Intravitreal Injections; Male; Middle Aged; Retinal Diseases; Tomography, X-Ray Computed; Vitrectomy | 2015 |
Presumed macular toxicity of intravitreal antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Eye Foreign Bodies; Humans; Injections; Macula Lutea; Retinal Diseases; Surgical Wound Infection; Vancomycin; Vitreous Body | 2006 |
Aminoglycoside toxicity in the treatment of endophthalmitis.
Topics: Amikacin; Endophthalmitis; Gentamicins; Humans; Ischemia; Ophthalmic Solutions; Retinal Diseases; Retinal Vessels | 1995 |
Toxic retinopathy secondary to repeat intravitreal amikacin and vancomycin.
Topics: Amikacin; Child; Endophthalmitis; Eye Injuries, Penetrating; Humans; Male; Retinal Diseases; Vancomycin | 1994 |
Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Study Group.
Topics: Aged; Amikacin; Bacteria; Endophthalmitis; Eye Infections, Bacterial; Female; Gentamicins; Humans; Injections, Intravenous; Macula Lutea; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Retinal Diseases | 1994 |
[Toxic retinopathy caused by intravitreal injection of amikacin and vancomycin].
Topics: Amikacin; Anti-Bacterial Agents; Corneal Injuries; Drug Therapy, Combination; Eye Injuries, Penetrating; Humans; Injections; Male; Middle Aged; Retinal Diseases; Vancomycin; Vitreous Body | 1996 |
The pH of antibiotic vitreous infusion combinations: a potential cause of retinal toxicity.
Topics: Amikacin; Anti-Bacterial Agents; Buffers; Drug Therapy, Combination; Humans; Hydrogen-Ion Concentration; Methicillin; Ophthalmic Solutions; Retinal Diseases; Therapeutic Irrigation; Tobramycin; Vancomycin; Vitreous Body | 1992 |